Stock ABERA ABERA BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Abera Bioscience AB

Equities

ABERA

SE0015245097

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.71 SEK -1.26% Intraday chart for Abera Bioscience AB -1.67% -8.72%
Feb. 09 Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Abera Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Abera Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
Abera Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Abera Bioscience : France's Avril in talks with Bigard group to sell two pork firms
RE
Abera Bioscience AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Abera Bioscience AB announced that it expects to receive SEK 17.049754 million in funding
CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Abera Bioscience AB has completed an IPO in the amount of SEK 24.081 million.
CI
Abera Bioscience AB has filed an IPO in the amount of SEK 24.081 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABERA Stock
  4. News Abera Bioscience AB